Hemodiafiltration (HDF) with online production of substitution fluid has emerged as kidney replacement therapy and is increasingly adopted worldwide. Recent randomized controlled trials, individual participant data meta-analyses, and large real-world studies have demonstrated that high-volume HDF improves clinical outc...
P. Blankestijn, Sanne Roos, Claudia Barth et al.· Journal of the American Soci...· 0 citations
BACKGROUND
Online hemodiafiltration (HDF) enhances the removal of middle molecules, including large-middle molecules, through the combined action of diffusion and convection. Randomized controlled trials (RCTs) and individual participant data (IPD) meta-analyses demonstrate improved cardiovascular outcomes and, importa...
Giovanni F. M. Strippoli, Giovanni Pellegrino, Jörgen Hegbrant et al.· JN. Journal of Nephrology (M...· 0 citations
Background Patient-reported outcome (PRO) measures are increasingly used in clinical trials and clinical care to assess symptoms, functioning, and health-related quality of life (HRQoL). In dialysis research, instrument-driven approaches that rely on legacy measures may not fully capture outcomes that matter most to pa...
Kathrin I. Fischer, K. Cromm, P. Blankestijn et al.· Frontiers in Nephrology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
